Delivery Order SPE2DB22D3301-SPE2DB24FY4YE
- Not listed
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,019.04 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major supplier of pharmaceuticals and medical supplies to the U.S. government, through its Corporate Office division. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,389.84 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,595.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that DLA Troop Support Medical has with Amerisourcebergen, valued up to $999,999,999 through December 2025, for providing a wide range of pharmaceutical and medical supplies to support military...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,470.89 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award, valued at $2,375.10, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,371.22 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 11, 2023, with a completion date of May 12, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The $1,437.02 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- This contract award provides for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $1,521.66 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on June 28, 2024. It has an ultimate completion date of July 1, 2024 and is not set aside for any specific business category. Amerisourcebergen holds...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,113.43, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed-price pricing type, with a completion date of February 26, 2024. Amerisourcebergen holds a significant...
- This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,478.97, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 18, 2024. Amerisourcebergen Drug Corp...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY4YEDelivery Order
The federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,796.62 firm fixed-price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, in support of the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. There is no set-aside designation for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/17/24 |